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Pneumococcal cell wall induces meningeal inflammation in rabbits injected intracister-
nally with >105 cell equivalents. Both of the major cell wall components, teichoic acid
and peptidoglycan, contribute to this inflammatory activity although responses differ
depending on the chemical nature, size,and complexity of these fractions. Challenge with
teichoic acid (membrane or wall associated) results in greater inflammation at 5 hr than
at 24 hr. Degraded teichoic acid is inactive. In contrast, the inflammation caused by whole
cell wall or high-molecular-weight peptidoglycan-containing fractions increases in inten-
sity from 5 to 24 hr. Peptidoglycan fractions lose activity at 24 hr when hydrolyzed to
disaccharide-stempeptide moieties. Generation of free cellwallcomponents in cerebrospinal
fluid as, for example, during treatment with antibiotics that are bacteriolytic as well as
bactericidal, could contribute to increased inflammation in the subarachnoid space.
The cell wall of pneumococci, located under a layer
of capsular polysaccharide, remains surprisingly ac-
cessible to and reactive with the host environment
[1]. Wehave shown that meningeal inflammation in
rabbits is induced when whole pneumococci, with
or without capsular polysaccharide, reach a density
of >105 cfu/ml of CSF. This inflammatory response
is remarkably similar to the inflammation follow-
ing challenge with 105 cellequivalents of isolated cell
wall, but not of isolated capsule [2].Because the cell
wall is a complex macromolecule with many possi-
ble sites of interaction with several host defense sys-
tems, the identification of which cell wall compo-
nent(s) is active in inducing inflammation during
pneumococcal meningitis is of considerable impor-
tance.
The pneumococcal cell wall is composed of two
major polymers: a peptidoglycan and a ribitol-
phosphate teichoic acid of unusually complex struc-
ture that contains phosphorylcholine [3]. The inter-
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action of C-reactive protein and of certain myeloma
proteins with pneumococci occurs through the rec-
ognition of the teichoic acid-choline residues [4].
The teichoic acid component of the pneumococcal
cell wall can also trigger the alternative pathway of
complement activation in vitro [5], while both
teichoic acid and peptidoglycan seem to have the ca-
pacity to bind the C3b component of complement
[6].
It is not known which elements of the complex
structure of the cell wall are responsible for the vari-
ous interactions between the pneumococcus and the
invaded host in vivo.The studies to be described here
represent an attempt to answer this question in the
case of the host response characteristic of pneumo-
coccal meningitis. We tested whole pneumococcal
cell wall and various biochemically defined macro-
molecular components of the cell wall for specific
activity in provoking an inflammatory response
when introduced intracisternally into the subarach-
noid space of rabbits.
Materials and Methods
Streptococcus pneumoniae. Strain Au is an en-
capsulated Rockefeller University laboratory strain
(type II). Strains R6 and lyt 4-4 (an autolysin-defi-
cient tolerant transformant of strain R6) are unencap-
sulated strains originally derived from strain Au.
Meningitis model. Male chinchilla rabbits weigh-
ing 2 kg (Thome Farm, Biebarach der Riss, Federal
Republic of Germany) were prepared according to
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Figure 1. Summary of pneumococcal surface compo-
nents that were isolated as described in Materials and
Methods. Preparation H consists of disaccharide pen-
tapeptide subunits derived from lysozyme treatment of
preparation G. G = N-acetylglucosamine; M = N-
acetylmuramic acid; hatched area = teichoic acid;--
= stem peptide; TeA = trichloroacetic acid extraction;
amidase = treatment with N-acetylmuramic acid-L-
alanine amidase; lyt- = pneumococcus deficient in en-
dogenous amidase activity; secretion = components
secreted into medium upon treatment of strain lyt 4-4 with
0.024 JAg of penicillin/ml.
the method of Dacey and Sande [7] as described pre-
viously [2].Unless otherwise noted, a set of four rab-
bits was tested for each bacteria or bacterial com-
ponent inoculated. Each component was compared
for activity on a cell equivalent and on a weight ba-
sis. Immediately upon withdrawal, CSF samples were
analyzed for cfu and cytochemistry as described else-
where [2].
Preparation ofpneumococcal cell surface com-
ponents. The preparation of a wide variety of cell
surface components is described in the following sec-
tions. Because small variations in preparative tech-
niques can yield components of significantly differ-
ent natures, preparative methods are described in
detail. Figure 1 schematically depicts these cell wall
products.
1. Capsularpolysaccharide. Several chemically
different pneumococcal capsular polysaccharides
were used. The polyvalent (14)pneumococcal poly-
saccharide vaccine (Pneumovax'P; Merck Sharp &
Dohme, Rahway, NJ) and type II and type III cap-
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sular polysaccharides (Merck) were each dissolved
in pyrogen-free saline at concentrations of 2-5
mg/ml and were dialyzed against several changes of
the same solution. (Dialysis membrane was prepared
by boiling, soaking in 0.5 M EDTA, and then rins-
ing in pyrogen-free saline.)
2. Pneumococcal cell wall. Cell wall with cho-
line-containing teichoic acids (preparation A).
Strain R6 was grown in one-liter batches of a chemi-
cally defined medium [8] to a cell concentration of
1"\15 x 108 cfu/ml. The cells were harvested by cen-
trifugation and resuspended in 5 ml of saline, and
the resulting suspension was submerged in a boiling
water bath for 15min to inactivate the autolytic en-
zyme. The suspension was then transferred to a
cuvette of the Mickle disintegrator (Hampton, Mid-
dlesex, England) mixed with an equal volume ofglass
beads (Ballotini no. 13; l00-J,lm diameter; 3M, St.
Paul, Minnesota), and shaken at maximum ampli-
tude at 4 C for 3 hr. An airspace equal to the total
volume of the suspension was kept in the cuvettes
to allow efficient disruption. Next, the glass beads
were separated out by sedimentation, the suspension
was centrifuged at 3,000g for 3 min (Sorvall RC2B;
Sorvall, Newtown, Conn) to remove unbroken cells,
and the supernatant was centrifuged at 10,000g for
30 min to sediment out the cell wall material. Inspec-
tion by phase-contrast microscopy revealed only
amorphous debris in such preparations. This crude
cell wall material was extracted with 2% SDS at
90-100 C for 30 min. Detergent was removed with
six cycles of washings by centrifugation in distilled
water. The cells, resuspended in 0.1 M Tris-HCI
buffer (pH 8.0)containing 1mMMgCb, weretreated
at 37 C with pancreatic DNase I (50 ug/ml) plus
RNase (100ug/ml) for 2 hr followed by trypsin (100
ug/ml) plus 10mMCaCb for 10-12 hr. (All enzyme
preparations were of crystalline grade and were ob-
tained from Worthington Biochemicals, Freehold,
NJ.) Cell wall was sedimented by centrifugation
(10,000gfor 30 min) and resuspended in 5 ml of 2%
SDS at 90-100 C in a water bath for 30 min. Deter-
gent was removed by eight to 10 cycles of washing,
first in 1 M NaCI solution and then in distilled wa-
ter, and the purified wall was lyophilized. The com-
position of this cell wall material has been described
[9].
On occasion, the following additional steps of
purification were introduced. Cell wall (10 mg) was
extracted with 10-ml portions of the following rea-
gents at room temperature for 30 min each: 0.1 M
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Pneumococcal autolysin is an N-acetylmuramic
acid-t-alanine amidase capable of degrading pneu-
mococcal cell wall to two types of components
separable on the basis of their different molecular
sizes; the first, a high-molecular-weight glycan-
Figure 2. Top: Elution profile of the products of ami-
dase activity on pneumococcal cell wall. Cell wall was
hydrolyzed with N-acetylmuramic acid-t-alanine amidase
and prepared as described in Materials and Methods.
Peak I (fractions 46-60) represents high-molecular-weight
glycan containing all the cell wall teichoic acid (labeled
with pH]methyl choline; 0), as well as glycan with residu-
al peptides (labeled with [3H]lysine; .). Peak II (frac-
tions 105-150) represents lower molecular-weight peptides
released from the cell wall by the amidase (labeled with
PH]lysine only). Bottom: Elution profile of purified
Forssman antigen. Partially purified pH]methyl cho-
line-labeled Forssman antigen was passed through a
Sepharose-TEPC 15 myeloma protein affinity column as
described in Materials and Methods. Because the Forss-
man antigen was retained on the column through its phos-
phorylcholine residue, impurities could be removed by
washes with buffer (no pH]methyl choline appears in
fractions 1-15). Purified Forssman antigen was specifi-
cally eluted from the column upon the addition of phos-
phorylcholine (PC) to the eluting buffer ([3H]methyl
choline appears in fractions 17-21).
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EDTA, 8 MLiCI solution, and finally, acetone. Cell
wall was washed with six cyclesof distilled water and
relyophilized.
Cell wall with ethanolamine-containing teichoic
acid (preparation B). Ethanolamine-containing cell
wall was prepared by the same procedure described
above except that the bacteria weregrown in medium
in which the normal choline component (5 ug/ml)
was replaced by ethanolamine (20 IAg/ml). Such
pneumococci produce cell wall in which the choline
component of teichoic acid is biosynthetically
replaced by ethanolamine [10].
Peptidoglycan free of teichoic acid (preparation
C). Pneumococcal cell wall (10 mg) was extracted
with 5 ml of 5% trichloroacetic acid (TCA) at 100 C
for 30 min. This procedure resulted in the complete
solubilization (and degradation) of cell wall teichoic
acid with only nJ10OJo of peptidoglycan released [9].
Insoluble peptidoglycan was separated by centrifu-
gation, washed with eight changes (10 ml each) of
distilled water, and lyophilized.
Degraded cell wall teichoic acid (preparation
D). The TCA extract described above (preparation
C) contained teichoic acid in degraded form, as evi-
denced by its heterogeneity and lower molecular size
[9]. The extract was shaken with an equal volume
of ethyl ether to remove TCA. The water-phase (4.5
ml) was then dialyzed against four liters of distilled
water for two days and finally lyophilized.
Radioactively labeled cell wall (preparation
E). Strain R6 was grown in the chemically defined
medium supplemented with either [3H]methyl cho-
line (2 IACi and 5 IAg/ml of medium) or L-[4,53H]ly-
sine (51ACi and 221Ag/ml of medium). Cell wall was
prepared as described in preparation A above. The
specific radioactivities were in the range of 5.0-7.0
IACi/mg of the dry weight of the cell walls.
3. Cell wall degradation products. Amidase
product: peptide-poor glycan-teichoic acid complex
(preparation F). Twobatches of pneumococcal cell
wall (80 mg of preparation A) wereeach resuspended
in 3.5 ml of saline containing 10 roM of K2HP04
(pH 7.4; SP). One batch received 100 IAI [3H]methyl
choline-labeled cell wall (nJ105 cpm total) and the
other, 100 IAI [3H] lysine-labeled cell wall as tracers.
Each suspension received 0.3 lAg of pneumococcal
autolysin (400 IA1 containing approximately four units
of enzyme activity) prepared by a previously pub-
lished procedure [10]. The suspensions were in-
cubated at 30 C for 48 hr during which time en-
zymatic solubilization was monitored [11].
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teichoic acid complex containing all the cell wall
teichoic acid and glycan with some of the stem pep-
tides still attached and second, a lower molecular-
weight mixture of most of the cell wall peptides
[9-11]. Cell wall hydrolysates were centrifuged
(15,000 g for 30 min) and the supernatants lyophi-
lized, then dissolved in 1 ml of saline and layered
on a G75 Sephadex column (Pharmacia Fine Chem-
icals, Piscataway, NJ; 2.5 x 40 em) that was then
eluted with saline (flow rate, 60 mllhr; fraction size,
1.2 mI). The void volume was determined by blue
dextran, and 100-J.d portions of the fractions were
assayed for radioactivity in 4 ml of Ultraflourv by
using a scintillation spectrophotometer (Nuclear
Chicago, Hartsdale, NY). Figure 2 (top) shows the
elution profile. Fractions 40-60, representing the
high-molecular-weight glycan-teichoic acid complex
(peak I) were pooled, lyophilized, dissolved in dis-
tilled water, desalted by passing through a column
of Sephadex G-I0 (2.5 X 30 em), and lyophilized
(yield, 11.91 mg).
Peptidoglycan oligomers free of teichoic acid
(preparation 0). Strain lyt 4-4 was grown in the syn-
thetic medium supplemented with yeast extract [8].
At the cell concentration of 108 cfu/ml, the bacteria
were filtered (Millipore, Bedford, Mass; 0.45-f.illl pore
size) and resuspended in the same volume of
prewarmed, chemically defined medium [12] modi-
fied by omission of leucine, a nutritionally essential
amino acid for pneumococci. Another modification
was the lowering of the concentration of lysine from
230 ug to 8 j.tg, as well as lowering the concentration
of choline from 5 j.tg to 1 j.tg/ml. After incubation
at 37 C for 30 min, penicillin G (0.1 j.tg/ml) was
added. Fifteen minutes later 3 j.tCi of [3H]methyl-
choline/ml were added to one portion of the culture
and 3 j.tCi of ['Hllysine were added to another por-
tion, and the incubation was continued for 2 hr. Bac-
teria were then removed by centrifugation and the
supernatants sterile filtered (Millipore; 0.45-j.tm pore
size) and dialyzed extensively against distilled water
at 4 C. The dialysates wereconcentrated by vaccuum
dialysis in a collodion bag apparatus (Schleicher and
Schuell, Keene, NH).
Under the experimental conditions described,
pneumococci secrete into the medium two kinds of
cell wall polymers: nascent uncrosslinked peptidogly-
can (labeled with radioactive lysine) and nascent
teichoic acid (labeled with radioactive choline) [13].
These two polymers are not covalently linked to one
another, and they may be separated by affinity chro-
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matography on columns of Sepharose coupled with
myeloma TEPC-15, an immunoglobulin with high
affinity for the choline-phosphate residues that are
present in the pneumococcal teichoic acid [14]. Mu-
rine ascites fluid containing TEPC-15 myeloma pro-
tein was supplied by M. Potter of the National In-
stitutes of Allergy and Infectious Diseases (Bethesda,
Md). The TEPC-15 protein was isolated by using a
phosphorylcholine affinity column [15]. The mye-
loma protein was coupled to CNBr-activated
Sepharose 4B (Pharmacia) by using a published pro-
cedure [16]. TEPC-15 Sepharose (5-ml bed volume)
was equilibrated with 0.1M sodium borate (pH 8.0)
containing 0.15MNaCl. The concentrated dialyzed
extracts (1 mI) were loaded onto the column and the
columns were washed with the buffered borate so-
lution. All the [3H]lysine-Iabeled material (pep-
tidoglycan) was recovered in this step. The material
was dialyzed against distilled water and lyophilized.
Quantitative adsorption to vancomycin-Sepharose
columns and additional analytical data indicate that
this material was made up of strands of uncross-
linked pneumococcal peptidoglycan [13].
Lysozyme product (preparation H). Uncross-
linked pneumococcal peptidoglycan (10 j.tg of prep-
aration G) was resuspended in 1ml of 0.1 MK2HP04
buffer (pH 7.0), treated with egg-white lysozyme (1
j.tg; Sigma, St. Louis) at 37 C for 24 hr, and used
directly for intracisternal inoculation. The lyso-
zyme-cell wall digest was tested in the rabbit model
in parallel with a solution of lysozyme that was five
times more concentrated (5 ug of protein/ml of 0.1
MK2HP04 buffer) and that contained no cell wall.
Cell wallteichoicacidfree ofpeptidoglycan (prep-
aration I). [3H]Methylcholine-labeled cell wall
teichoic acid was recovered from the TEPC-15
columns (preparation G) in 80070-90% yield by spe-
cific elution with 2 mM phosphorylcholine in the
borate buffer. The elution was monitored for radio-
activity by assaying O.1-ml fractions in 4 ml of
Ultrafluor. Analytical work with this material indi-
cates that it is made up of a mixture of cell wall
teichoic acid (free of peptidoglycan) and membrane
teichoic acid (Forssman antigen), in a ratio of 'Vl:l
[13]. After dialysis against distilled water, the elu-
ates were lyophilized.
4. Forssman antigen (preparation J). Pneumo-
coccal Forssman antigen was prepared from a 20-
liter culture of strain R6 grown in synthetic medium
by using a modification [17] of the original proce-
dure of Goebel et al. [18]. A small (100 ml) culture
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Titration of inflammatory activity of purified
pneumococcal cell wall and capsular polysaccha-
ride. The CSF cytochemical profile induced by
pneumococcal cell wall with choline-containing
teichoic acid (preparation A) was compared with the
profile obtained with capsular polysaccharide (fig-
ure 3). Both cell wall and capsular polysaccharide
induced inflammatory changes in CSF at high doses
(2 mg/0.2 ml; 'V108 cell equivalents). Cell wall was
active, however, in doses as small as 0.2 ~g/0.2 ml
('V105 cellequivalents), whereascapsular polysaccha-
Figure 3. Titration of CSF inflammatory response to
isolated cell wall and capsular polysaccharide. Groups of
two rabbits were challenged with cell wall (all closed sym-
bols) or capsular polysaccharide (all open symbols). Each
component was instilled at three concentrations (suspend-
ed in 0.2 ml saline): 2 mg (circle), 2 IJg (square), 0.2 IJg
(triangle). The CSF was then sampled over the next 24
hr and the cytochemistry determined as described in the
text. Each point represents the mean ± SE.
A
B
F
c
5 10 15 20
HOURS
Figure 4. CSF white blood cell (WBC) response to cell
wall components. A group of four rabbits was challenged
with 2 IJg of one of the following preparations: choline-
containing cell wall (preparation A, ..); ethanolamine-
containing cell wall (preparation B, D); amidase product
(preparation F, .); crosslinked peptidoglycan stripped
of teichoic acid (preparation C, X); peptidoglycan
oligomers without teichoic acid (preparation G, 0); or
lysozyme digest (preparation H, ..6.). Lysozyme alone
produced only minimal inflammation (80 ± 20 WBC/1Jl)
at 5 hr. Determinations of WBC/IJI of CSF were made
as described in the text.
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of R6 was also grown in parallel in synthetic medium
containing [3H]methylcholine(5 ~Ci and 5 ~g/ml of
medium) for use as a tracer in the purification of
the choline-containing Forssman antigen. The
pelleted bacteria from this culture were pooled with
the pellet of the 20-liter culture at the beginning of
the extraction procedure. The final water extract
yielded 9 mg of dry material, out of which 1'\.12.6 mg
was protein. Most of this protein impurity was re-
moved during passage of the material (4.5 mg in 1.5
ml SP) through a Sepharose-myeloma TEPC-15 pro-
tein affinity column (8 ml). After washing the
column with 3.5 bed volumes of SP, the Forssman
antigen was eluted with 10 ml of SP containing 5
mM phosphorylcholine. Elution was monitored by
determining radioactivity in the eluant (figure 2, bot-
tom). Fractions 17-21 werepooled and, after exten-
sivedialysis against distilled water, the material was
lyophilized (yield, 1.5 mg of dry material).
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Figure 5. CSF leukocyte response to cell wall teichoic
acid, membrane teichoic acid, or capsular polysaccharide.
A group of four rabbits was challenged with 21-lg of one
of the following preparations: cell wall teichoic acid
(preparation I, .); Forssman antigen (membrane teichoic
acid, preparation J, _); degraded teichoic acid (prepa-
ration D, 0); or capsular polysaccharide (X). CSF de-
terminations were made as described in Figure 4.
or of teichoic acid only modestly augmented this
activity.
CSFinflammatory response to teichoic acid. The
activity of the mixture of cell wall teichoic acid (free
of peptidoglycan) and Forssman antigen (prepara-
tion I) is depicted in figure 5. The peak of activity
for teichoic acid-containing preparations was at 5
hr after inoculation, in contrast to 24 hr after in-
oculation for peptidoglycan-containing prepara-
tions. Teichoic acid proved to have the highest spe-
cific activity of all cell wall fractions on a weight
basis. CSF leukocyte density 5 hr after inoculation
was 10times higher following instillation ofteichoic
acid than following instillation of the most active
teichoic acid-free cell wall preparations. Virtually
all of the activity associated with the teichoic acid
was lost upon degradation to small fragments with
ride was not active at doses of 200, 20, or 2 Ilg/ml.
The magnitude of the CSF leukocytosis varied
directly with the concentration of cell wall intro-
duced, e.g., leukocytes appeared both sooner and in
greater number as the concentration of cell wall was
raised. The minimum concentration of cell wall that
could induce changes in each component of the CSF
response varied: lactic acid, 20 Ilg/0.2 ml; leukocyte,
2Ilg/0.2 ml; protein, 0.2Ilg/0.2 ml. CSF glucose con-
centration failed to decrease with any nonliving in-
oculum.
Comparison of peptidoglycan-containing frac-
tions ofcell wallfor activity in inducing CSFinflam-
mation. All pneumococcal peptidoglycan fractions
(preparations A, B, C, F, and G), regardless of size
or complexity, induced a CSF inflammatory re-
sponse 5 hr after intracisternal instillation (figure 4).
The initial leukocyte concentration ranged between
200-600 cells/ill, and> 60070 of these were PMNLs.
The leukocyte response shifted to a predominance
of lymphocytes by 24 hr after inoculation. This is
the same response observable during meningeal in-
flammation induced by live pneumococci. Protein
and lactic acid concentrations increased in parallel
with the leukocytes.
While peptidoglycan-containing fractions pro-
duced similar inflammatory responses in the first few
hours after intracisternal inoculation, the evolution
of inflammation over 24 hr was quite different for
the various fractions. Fractions containing large, in-
soluble cell wall particles were the most potent in-
ducers of leukocytosis whether they contained cho-
line (preparation A) or ethanolamine (preparation
B; figure 4). The activity of preparation A was un-
changed even when extensively purified to remove
divalent cations (EDTA treatment) and adsorbed
teichoic acid (LiCI treatment). Removal of most of
the stem peptides by amidase (as induced by peni-
cillin; preparation F) or teichoic acid by hot TCA
(preparation C) reduced the magnitude of the leu-
kocytosis. These responses to soluble cell wall frac-
tions remained similar to whole cell wall, however,
in that the leukocyte numbers were higher at 24 hr
than at 5 hr after inoculation. Activity 24 hr after
inoculation was dramatically reduced in the case of
peptidoglycan oligomers that were soluble and un-
crosslinked and their lysozyme-degraded low-molec-
ular-weight products (preparations G and H). Thus,
the larger size of the polysaccharide backbone of the
peptidoglycan oligomers seemedcritical to the main-
tenance of a CSF inflammatory response beyond
5 hr; the presence of a complete peptide network
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hot TCA (figure 5; preparation D). Forssman anti-
gen represents the lipid-containing membrane-
associated teichoic acid. Titration of the activity of
this component in the rabbit model yielded results
very similar to preparation I (figure 5).
Phosphorylcholine is a characteristic component
of pneumococcal teichoic acid. When this compo-
nent is changed to phosphorylethanolamine several
surface characteristics of the organism change, e.g.,
lack of daughter cell separation and sensitivity to
endogenous autolysin [19]. The possibility that the
reactivity of cell wall preparations in CSF would be
altered by this substitution was studied by compari-
son of cell wall derived from organisms grown in
medium containing choline or containing ethanola-
mine. Although ethanolamine-containing cell wall
(preparation B) was less active in the initial 5 hr of
the inflammatory response, both preparations A and
B were equally active when assessed at 24 hr (P
> .05; figure4). Thus, a specificalteration in the com-
position of teichoic acid had little effect on the CSF
inflammatory reaction.
Discussion
Pneumococcal cell wall appears to be a potent acti-
vator of meningeal inflammation in vivo. These
studies demonstrated that each of the major com-
ponents of the cell wall- peptidoglycan and teichoic
acid - could contribute to the induction of inflam-
mation. Each had specific activity high enough to
produce an inflammatory reaction if given at doses
~105 cell equivalents. In contrast, the specificinflam-
matory activity of capsular material was 1,OOO-feld
lower, a level insufficient to provoke inflammation
at concentrations of capsule found in CSF during
meningitis [20]. These findings are summarized in
table 1.
Teichoic acid had the highest specific activity (on
a weight basis) of all the cell wall fractions with the
peak activity occurring 5 hr after instillation. In con-
trast, peptidoglycan-containing fractions invoked in-
creasesin concentrations of CSF leukocytes, protein,
and lactic acid that were greater 24 hr after inocu-
lation.
Inflammatory activity occurred whether the cell
wall fraction was soluble or not. Activity was
markedly reduced, however,if either the peptidogly-
can or the teichoic acid was extensively degraded
(preparations H and D). This finding, taken together
with both the high activity of the affinity-purified
fractions (preparations G, I, and J) and the absence
of activity in column effluents, strongly supports the
contention that the cell wall components, and not
an undefined contaminant, are responsible for in-
ducing the inflammation.
Table 1. CSF inflammatory activity of pneumococcal surface components in a rabbit model of meningitis.
Inflammatory
activity Preparation
+ A
+ B
Purified
+ A
+ C
D
H
+ F
+ G
+ I
+ J
Surface component
Cell wall
Choline-teichoic acid
Ethanolamine-teichoic acid
Without divalent cation, adsorbed
teichoic acid, or adsorbed
lipoteichoic acid
Without teichoic acid
Peptidoglycan
Degraded teichoic acid
Degraded peptidoglycan
Glycan-teichoic acid polymers
Penicillin-treated lyt: cells
Uncrosslinked peptidoglycan
Nascent teichoic acid
Pneumococcal plasma membrane
Forssman antigen
Pneumococcal capsular polysaccharide
Pneumovax
Type III
NOTE. Relative activity of surface components, 5 hr after inoculation, in inducing abnormal CSF cytochemistry. Components
were introduced at rv106 cell equivalents. (+) = active; (-) = inactive.
866
The inflammatory activity of cell wall and several
of its fractions has significant biological relevance
in that these fractions could be generated in CSF dur-
ing the course of meningitis. For instance, because
both choline and ethanolamine are present in CSF
[21], teichoic acid containing either amino alcohol
could be produced during pneumococcal growth in
vivo. The inflammatory activity of choline- and
ethanolamine-containing cell wall are similar, how-
ever, and the course of inflammation would not be
expected to change if this shift in growth conditions
wereto occur. Other fractions of pneumococcal cell
wall could also be generated during the course of
meningitis in vivo, particularly during antibiotic ther-
apy. The peptidoglycan-teichoic acid complex pro-
duced by the action of the pneumococcal autolytic
enzyme (amidase) on whole cell wall (preparation
F) appears in culture supernatants following treat-
ment of pneumococci with fJ-Iactam antibiotics [1,
22]. This complex is also generated during sponta-
neous autolysis of stationary-phase cells [1]. Nascent
peptidoglycan (preparation G) and teichoic acid
(preparation I) are secreted, unassociated with each
other, during fJ-Iactam treatment of tolerant pneu-
mococci [13], such as the South African pneumo-
coccal strain 8249 that is multiply resistant [23].
Forssman antigen (preparation J) is readily secreted
upon treatment of all pneumococci with fJ-Iactam
antibiotics [24]. It is accessible to host interactions
even in living, encapsulated cells as evidenced by
both the production of antibody to Forssman anti-
gen upon challenge with whole organisms [25) and
its putative role as a pneumococcal adhesin [26].
Thus, whole pneumococcal cell wall and several of
its components are good candidates for initiation or
augmentation of inflammation during the course of
meningitis in vivo.
The mechanism wherebycell wallor.cell wall frac-
tions act as chemotaxins is as yet undefined. The in-
flammatory response could ensue in either of two
ways: first, by activation of host defense systemsthat
generate chemotaxins, or second, by direct interac-
tion between cell wall and host cells.
In the first case, a likely mechanism may involve
complement [27] or C-reactive protein (CRP). The
alternative pathway of complement is specificallyac-
tivated by teichoic acid and to a lesser extent by large
peptidoglycan units [5, 6, 28]. The inflammatory re-
sponse would, perhaps, be expected to appear ear-
lier and might be more intense if complement were
activated in CSF. This may explain in part the rapid
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onset and high-specificactivity ofteichoic acid-con-
taining cell wall components. CRP has been demon-
strated in CSF [29] and is known to promote com-
plement activation by interacting with teichoic
acid-associated phosphorylcholine [4, 30, 31]. The
finding that cell wall containing either ethanolamine
or choline produces similar inflammatory responses
in rabbits is consistent with the fact that rabbit CRP
reacts equally well with either of these two cell wall
preparations [32]. It must be noted, however, that
complement is not known to fix to small peptidogly-
can units [33], yet these components are effective at
inducing inflammation. In addition, CSF contains
very little complement even late in the course of
meningitis [34, 35]. It would be more reasonable,
therefore, to predict that while complement-
dependent chemotaxins may contribute to the in-
flammatory response in meningitis, they may not be
the only mechanism for its generation.
In the second case, noncomplement-derived
chemotaxins have been described in CSF [36,37]and
are potentially attributable to direct interaction be-
tween bacterial components themselvesand host cells
[38, 39]. Cell wall could potentially interact directly
with CSF monocytes and stimulate production of
chemotaxins (e.g., leukotriene B4 ) without involving
complement. Preliminary data from our studies in
complement-depleted animals are compatible with
this hypothesis. Such an interaction presumes the ex-
istence of a receptor for cellwallcomponents on host
cells. Such a host cell receptor had been proposed
to be on the surface of epithelial cells for the mem-
brane analogue of cell wall teichoic acid - Forssman
antigen [26]. It is conceivable that receptors for this
amphipathic molecule or for other cell wall compo-
nent(s) may be present on the meningeal membrane
lining all or part of the CSF space.
Our findings strongly suggest that the inflamma-
tory reaction in pneumococcal meningitis derives,
at least in part, from component(s) of the bacterial
cell wall rather than from the capsule. The genera-
tion of an inflammatory response in the course of
natural infection servesto control bacterial multipli-
cation. Our evidencesuggests,however, that bacterial
lytic products such as cell wall released during drug-
induced autolysis, may represent a reservoir of in-
flammatory products that could contribute to fur-
ther injury to host tissues including, perhaps,
mortality despite effectiveCSF sterilization. Wesug-
gest that exploring avenues of antibacterial therapy
that are bactericidal but nonbacteriolytic may lead
Meningeal Inflammation and Pneumococci
to methods of treatment that diminish the overall
host inflammatory response and may, conceivably,
improve the overall morbidity and mortality of pneu-
mococcal meningitis.
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